We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTX icon
576
MarketAxess Holdings
MKTX
$4.41B
$870K 0.01%
3,397
+735
+28% +$172K
AEM icon
577
Agnico Eagle Mines
AEM
$70.3B
$824K ﹤0.01%
10,216
+1,309
+15% +$101K
HURN icon
578
Huron Consulting
HURN
$2.57B
$812K ﹤0.01%
7,470
KMX icon
579
CarMax
KMX
$8.52B
$801K ﹤0.01%
10,349
FCNCA icon
580
First Citizens BancShares
FCNCA
$24.9B
$797K ﹤0.01%
433
-14
-3% -$26.7K
BN icon
581
Brookfield
BN
$102B
$777K ﹤0.01%
21,914
-705
-3% -$22.3K
CF icon
582
CF Industries
CF
$19.4B
$769K ﹤0.01%
8,961
+1,766
+25% +$137K
SUI icon
583
Sun Communities
SUI
$15.5B
$756K ﹤0.01%
5,592
+772
+16% +$102K
PBA icon
584
Pembina Pipeline
PBA
$29.4B
$752K ﹤0.01%
18,222
+2,028
+13% +$79.3K
GEV icon
585
GE Vernova
GEV
$245B
$752K ﹤0.01%
2,949
-344
-10% -$66.1K
BMO icon
586
Bank of Montreal
BMO
$124B
$744K ﹤0.01%
8,238
+1,800
+28% +$154K
SLF icon
587
Sun Life Financial
SLF
$46.2B
$733K ﹤0.01%
12,628
+536
+4% +$28K
DLTR icon
588
Dollar Tree
DLTR
$24.6B
$715K ﹤0.01%
10,172
-364
-3% -$33.2K
LYV icon
589
Live Nation Entertainment
LYV
$41.8B
$695K ﹤0.01%
6,352
+1,090
+21% +$105K
CTRA
590
DELISTED
Coterra Energy
CTRA
$695K ﹤0.01%
29,023
-9,738
-25% -$240K
DPZ icon
591
Domino's
DPZ
$11.9B
$665K ﹤0.01%
1,546
MCHP icon
592
Microchip Technology
MCHP
$39.4B
$654K ﹤0.01%
8,145
-3,557
-30% -$294K
MOS icon
593
The Mosaic Company
MOS
$7.17B
$620K ﹤0.01%
23,136
+3,424
+17% +$94.2K
SNAP icon
594
Snap
SNAP
$7.96B
$609K ﹤0.01%
56,933
-1,333
-2% -$15.2K
SKM icon
595
SK Telecom
SKM
$11.6B
0
RIVN icon
596
Rivian
RIVN
$23.7B
$595K ﹤0.01%
53,039
-1,133
-2% -$16.3K
WPC icon
597
W.P. Carey
WPC
$17.1B
$566K ﹤0.01%
9,090
+1,678
+23% +$99.5K
FOXA icon
598
Fox Class A
FOXA
$24.5B
$551K ﹤0.01%
13,007
-470
-3% -$18.2K
KIDS icon
599
OrthoPediatrics
KIDS
$512M
$520K ﹤0.01%
19,165
ENB icon
600
Enbridge
ENB
$122B
$507K ﹤0.01%
12,476
+976
+8% +$37.6K

Similar funds

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.